Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage
Related Posts
The earnings picture for stocks is deteriorating. How worried investors should be
Investors are counting on solid earnings growth to propel stocks even higher in 2025, but estimates are showing signs of cooling.
Stock futures tick lower as investors await Federal Reserve’s interest rate decision: Live updates
The Federal Reserve is poised to make its first decision on interest rates in 2025.
Trump PAC has raised about $7.5 million in crypto donations since early June
A political action committee supporting Donald Trump’s presidential bid has raised about $7.5 million in cryptocurrencies.